Dose-response in monotherapy In a direct comparison with 90 micrograms, the 180 micrograms-dose was associated with superior sustained virological response in patients with cirrhosis, but in a study in non-cirrhotic patients very similar results were obtained with doses of 135 micrograms and 180 micrograms.
Toisaalta tulokset 135 mikrog: n ja 180 mikrog: n annoksilla olivat hyvin samanlaiset potilailla, joilla ei ollut maksakirroosia.